Ascrinvacumab (Anti-ACVRL1 / ALK-1)
Ascrinvacumab (Anti-ACVRL1 / ALK-1) is a human IgG2 monoclonal antibody targeting ALK-1. It can be used for the treatment of hepatocellular carcinoma (HCC), in patients with advanced solid tumors. It also demonstrates its use in antiangiogenic therapy. MW : 150 KD.
Trivial name | PF-03446962 |
Catalog Number | A2594 |
CAS# | 1463459-96-2 |
Size | 1mg*25 |
Supplier Page | http://www.selleckchem.com/products/ascrinvacumab-anti-acvrl1-alk-1.html |